For this SPRINGBOARD®, panelists with competencies/experience within these themes, are needed for sparring:

Description
The company is licensing technology to transform insect storage and shipment. StayPrime, our patent-pending technology, extends insect larvae shelf life by two weeks, unlocking market potential across food/feed, pest control, and pollination industries. Our first commercial license, ongoing R&D contracts, positive cash flow, and zero debt underscore strong traction and financial stability. The company champions eco-friendly insect farming as a sustainable alternative to traditional agriculture.
Problem
Insect production is hindered by variable egg output, short shelf life, high transport mortality, and limited performance—impeding scalability and adoption.
Solution
Our key product, StayPrime is a novel technology that induces reversible larval suspension, extending shelf life to two weeks while enhancing performance and enabling cost-effective shipping and storage.
Market Opportunity
• €3.7B by 2032 (food/feed insects).
• €29.43B by 2030 (pest control).
• €27.5B annually (pollination).
The shift toward decentralized, cost-competitive insect farms creates ideal conditions for StayPrime's adoption, with untapped potential in pest control and pollination markets.
Go-to-Market Strategy
Start with licensing partnerships in the food/feed sector, followed by targeted expansion into pest control and pollination. Leverage partnerships to promote future product pipeline.
Business Model
Tiered licensing: initial testing, paid extended validation, and an annual license (€50,000), creating recurring revenue and lasting partnerships.
Competition
StayPrime outperforms competitors like Evo Conversion System, Nasekomo, and FreezeM through cost-effectiveness, versatility, and ease of implementation across species and larval stages.
Status and Traction
• Positive technical evaluation of patent application in Denmark.
• First customer (FarmInsect) reporting positive results.
• 5 ongoing R&D trialsand extend licensing contract.
• Proven efficacy across multiple insect species.
• Active development of new products.
Team
• Anton (R&D): 9+ years in insect R&D and project management.
• Daniel (Sales): 9+ years in EU automation sales.
• Claus (Investment): Expert in investment and strategic guidance.